PetIQ/PETQ

$18.28

3.39%
-
1D1W1MYTD1YMAX

About PetIQ

PetIQ, Inc. is a pet medication and wellness company, which provides veterinary products and services. The Company is engaged with customers through approximately 60,000 points of distribution across retail and e-commerce channels. The Company has two segments: Products and Services. Products segment manufactures and distributes pet medication and health and wellness products to the retail and e-commerce channels. It is focused its offerings on value-branded products, and third-party branded products for dogs and cats, including pet Rx medications, OTC medications, and wellness products. It offers and supplies these products to customers primarily in the United States. Services segment provides a comprehensive suite of services at approximately 2,600 community clinic locations and wellness centers hosted at retailers across 41 states. The segment’s services include diagnostic tests, vaccinations, prescription medications, microchipping, grooming and hygiene and wellness checks.
Ticker
PETQ
Sector
Healthcare
Trading on
NASDAQ
Industry
Biotechnology & Drugs
CEO
McCord Christensen
Employees
1,888
Headquarters
Eagle, United States
Website
petiq.com

PetIQ Metrics

BasicAdvanced
$537.93M
Market cap
43.07
P/E ratio
$0.42
EPS
1.65
Beta
-
Dividend rate

What the Analysts think about PetIQ

Analyst Ratings

Majority rating from 6 analysts.
Buy

Price Targets

Average projection from 3 analysts.
45.9% upside
High $30.00
Low $22.00
$18.28
Current price
$26.67
Average price target

PetIQ Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
0.14% profit margin
QuarterlyAnnual
Q3 23
QoQ growth
Revenue
$277M
-11.92%
Net income
$400K
-95.74%
Profit margin
0.14%
-95.3%

PetIQ Earnings Performance

Earnings per share (EPS)

Company profitability
Beat by 2,300%
QuarterlyAnnual
Q4 22
Q1 23
Q2 23
Q3 23
Q4 23
Actual
-$0.10
$0.45
$0.46
$0.42
-
Expected
-$0.09
$0.35
$0.26
$0.02
-$0.29
Surprise
6.38%
29.5%
76.92%
2,300%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.

Upcoming events

Buy or sell PetIQ stock

Buy or sell PetIQ stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing